Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Su

Showing results (31-40 of 512) with videos related to

Pageof 52
Sort By:
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016A Bienek, M Heisz, M Su
Trends in Molecular Medicine|August 10, 2010
IDH mutations in glioma and acute myeloid leukemiaLenny Dang, Shengfang Jin, Shinsan M Su
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 1, 1994
[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia]Y K Shi, Y Sun, M Su
The New England Journal of Medicine|January 17, 2002
Treatment of out-of-hospital status epilepticusM Su, A Chodosh, L S Nelson
Archives of Virology|January 1, 1982
Rapid and sensitive heterologous enzyme immunoassays for densonucleosis virus (Parvoviridae)P Tijssen, D M Su, E Kurstak
Journal of Microscopy|November 2, 2004
A convenient and rapid sample repositioning approach for atomic force microscopyM Su, Z Pan, V P Dravid
Somatic Cell and Molecular Genetics|March 1, 1996
Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiationF S Pardo, M Su, C Borek
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 23, 2019
Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015-October 2017D Pomerleau-Normandin, M Heisz, M Su
No Shinkei Geka. Neurological Surgery|September 23, 1997
[Multiple brain metastasis of bronchial atypical carcinoid: unusual MR imaging, case report]T Kon, N Hara, M Su, et al.
The Laryngoscope|April 18, 2020
To Vaccinate or Not to Vaccinate: Should Adults Aged 26 to 45 Years Receive the Human Papillomavirus Vaccine?Brooke M Su-Velez, Maie A St John
Pageof 52

Showing results (31-40 of 512) with videos related to

Sort By:
Pageof 52
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016A Bienek, M Heisz, M Su
Trends in Molecular Medicine|August 10, 2010
IDH mutations in glioma and acute myeloid leukemiaLenny Dang, Shengfang Jin, Shinsan M Su
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 1, 1994
[Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia]Y K Shi, Y Sun, M Su
The New England Journal of Medicine|January 17, 2002
Treatment of out-of-hospital status epilepticusM Su, A Chodosh, L S Nelson
Archives of Virology|January 1, 1982
Rapid and sensitive heterologous enzyme immunoassays for densonucleosis virus (Parvoviridae)P Tijssen, D M Su, E Kurstak
Journal of Microscopy|November 2, 2004
A convenient and rapid sample repositioning approach for atomic force microscopyM Su, Z Pan, V P Dravid
Somatic Cell and Molecular Genetics|March 1, 1996
Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiationF S Pardo, M Su, C Borek
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 23, 2019
Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015-October 2017D Pomerleau-Normandin, M Heisz, M Su
No Shinkei Geka. Neurological Surgery|September 23, 1997
[Multiple brain metastasis of bronchial atypical carcinoid: unusual MR imaging, case report]T Kon, N Hara, M Su, et al.
The Laryngoscope|April 18, 2020
To Vaccinate or Not to Vaccinate: Should Adults Aged 26 to 45 Years Receive the Human Papillomavirus Vaccine?Brooke M Su-Velez, Maie A St John
Pageof 52